Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
DLHC vs SGBX vs HCSG vs VSEC vs CRAI
Revenue, margins, valuation, and 5-year total return — side by side.
Manufacturing - Metal Fabrication
Medical - Care Facilities
Aerospace & Defense
Consulting Services
DLHC vs SGBX vs HCSG vs VSEC vs CRAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Manufacturing - Metal Fabrication | Medical - Care Facilities | Aerospace & Defense | Consulting Services |
| Market Cap | $83M | $33K | $1.60B | $4.56B | $899M |
| Revenue (TTM) | $293M | $3M | $1.84B | $1.18B | $771M |
| Net Income (TTM) | $-4M | $-19M | $59M | $63M | $48M |
| Gross Margin | 14.4% | -87.3% | 13.3% | 12.2% | 20.3% |
| Operating Margin | 2.5% | -375.8% | 3.0% | 10.7% | 9.8% |
| Forward P/E | 60.8x | — | 20.8x | 47.9x | 16.9x |
| Total Debt | $145M | $7M | $25M | $343M | $127M |
| Cash & Equiv. | $125K | $376K | $161M | $69M | $18M |
DLHC vs SGBX vs HCSG vs VSEC vs CRAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DLH Holdings Corp. (DLHC) | 100 | 77.4 | -22.6% |
| Safe & Green Holdin… (SGBX) | 100 | 0.1 | -99.9% |
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| VSE Corporation (VSEC) | 100 | 767.1 | +667.1% |
| CRA International, … (CRAI) | 100 | 344.4 | +244.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DLHC vs SGBX vs HCSG vs VSEC vs CRAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DLHC lags the leaders in this set but could rank higher in a more targeted comparison.
SGBX is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.45, yield 100.0%
- Beta 0.45, yield 100.0%, current ratio 0.08x
- Beta 0.45 vs VSEC's 1.93
- 100.0% yield, 1-year raise streak, vs CRAI's 1.5%, (2 stocks pay no dividend)
HCSG is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.12, Low D/E 4.8%, current ratio 3.38x
VSEC ranks third and is worth considering specifically for momentum.
- +57.0% vs SGBX's -96.3%
CRAI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 9.3%, EPS growth 20.8%, 3Y rev CAGR 8.3%
- 5.5% 10Y total return vs VSEC's 5.2%
- 9.3% revenue growth vs SGBX's -69.9%
- Lower P/E (16.9x vs 47.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.3% revenue growth vs SGBX's -69.9% | |
| Value | Lower P/E (16.9x vs 47.9x) | |
| Quality / Margins | 6.2% margin vs SGBX's -5.7% | |
| Stability / Safety | Beta 0.45 vs VSEC's 1.93 | |
| Dividends | 100.0% yield, 1-year raise streak, vs CRAI's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +57.0% vs SGBX's -96.3% | |
| Efficiency (ROA) | 7.6% ROA vs SGBX's -35.6%, ROIC 20.4% vs -625.7% |
DLHC vs SGBX vs HCSG vs VSEC vs CRAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DLHC vs SGBX vs HCSG vs VSEC vs CRAI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VSEC leads in 2 of 6 categories
DLHC leads 1 • SGBX leads 0 • HCSG leads 0 • CRAI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VSEC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HCSG is the larger business by revenue, generating $1.8B annually — 543.1x SGBX's $3M. CRAI is the more profitable business, keeping 6.2% of every revenue dollar as net income compared to SGBX's -5.7%. On growth, VSEC holds the edge at +26.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $293M | $3M | $1.8B | $1.2B | $771M |
| EBITDAEarnings before interest/tax | $25M | -$12M | $72M | $170M | $98M |
| Net IncomeAfter-tax profit | -$4M | -$19M | $59M | $63M | $48M |
| Free Cash FlowCash after capex | $19M | -$5M | $139M | -$14M | -$17M |
| Gross MarginGross profit ÷ Revenue | +14.4% | -87.3% | +13.3% | +12.2% | +20.3% |
| Operating MarginEBIT ÷ Revenue | +2.5% | -3.8% | +3.0% | +10.7% | +9.8% |
| Net MarginNet income ÷ Revenue | -1.5% | -5.7% | +3.2% | +5.3% | +6.2% |
| FCF MarginFCF ÷ Revenue | +6.5% | -155.0% | +7.6% | -1.1% | -2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -33.6% | -40.0% | +6.6% | +26.8% | +10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.0% | +88.9% | +175.0% | +3.4% | -35.5% |
Valuation Metrics
DLHC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 17.1x trailing earnings, CRAI trades at a 78% valuation discount to VSEC's 79.1x P/E. On an enterprise value basis, DLHC's 6.7x EV/EBITDA is more attractive than VSEC's 29.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $83M | $32,963 | $1.6B | $4.6B | $899M |
| Enterprise ValueMkt cap + debt − cash | $228M | $7M | $1.5B | $4.8B | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | 60.83x | -0.00x | 27.54x | 79.15x | 17.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 20.83x | 47.91x | 16.88x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 0.79x |
| EV / EBITDAEnterprise value multiple | 6.71x | — | 22.38x | 29.30x | 10.36x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 0.01x | 0.87x | 4.10x | 1.20x |
| Price / BookPrice ÷ Book value/share | 0.73x | — | 3.19x | 2.94x | 4.37x |
| Price / FCFMarket cap ÷ FCF | 3.61x | — | 11.49x | 798.59x | 48.45x |
Profitability & Efficiency
Evenly matched — HCSG and CRAI each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
CRAI delivers a 23.6% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-77 for SGBX. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to DLHC's 1.28x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs SGBX's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.0% | -77.2% | +11.8% | +4.1% | +23.6% |
| ROA (TTM)Return on assets | -1.6% | -35.6% | +7.3% | +3.0% | +7.6% |
| ROICReturn on invested capital | +4.7% | -625.7% | +9.0% | +5.9% | +20.4% |
| ROCEReturn on capital employed | +6.6% | — | +7.7% | +7.7% | +26.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 7 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.28x | — | 0.05x | 0.24x | 0.60x |
| Net DebtTotal debt minus cash | $145M | $7M | -$136M | $273M | $109M |
| Cash & Equiv.Liquid assets | $125,000 | $375,873 | $161M | $69M | $18M |
| Total DebtShort + long-term debt | $145M | $7M | $25M | $343M | $127M |
| Interest CoverageEBIT ÷ Interest expense | 0.46x | -13.81x | 33.02x | 8.72x | 14.51x |
Total Returns (Dividends Reinvested)
VSEC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VSEC five years ago would be worth $45,853 today (with dividends reinvested), compared to $5 for SGBX. Over the past 12 months, VSEC leads with a +57.0% total return vs SGBX's -96.3%. The 3-year compound annual growth rate (CAGR) favors VSEC at 61.0% vs SGBX's -87.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.7% | -52.9% | +28.6% | +10.1% | -30.3% |
| 1-Year ReturnPast 12 months | +41.5% | -96.3% | +55.8% | +57.0% | -20.7% |
| 3-Year ReturnCumulative with dividends | -44.1% | -99.8% | +48.6% | +317.6% | +54.1% |
| 5-Year ReturnCumulative with dividends | -44.0% | -100.0% | -21.1% | +358.5% | +71.5% |
| 10-Year ReturnCumulative with dividends | +24.0% | -100.0% | -26.8% | +517.9% | +550.5% |
| CAGR (3Y)Annualised 3-year return | -17.6% | -87.5% | +14.1% | +61.0% | +15.5% |
Risk & Volatility
Evenly matched — SGBX and HCSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
SGBX is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than VSEC's 1.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs SGBX's 1.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 0.45x | 1.12x | 1.93x | 0.73x |
| 52-Week HighHighest price in past year | $8.10 | $96.00 | $24.39 | $232.61 | $227.29 |
| 52-Week LowLowest price in past year | $3.95 | $0.79 | $12.66 | $121.75 | $135.95 |
| % of 52W HighCurrent price vs 52-week peak | +70.7% | +1.0% | +91.5% | +85.7% | +61.2% |
| RSI (14)Momentum oscillator 0–100 | 45.4 | 35.2 | 61.8 | 57.7 | 41.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 503K | 676K | 662K | 187K |
Analyst Outlook
Evenly matched — SGBX and HCSG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HCSG as "Hold", VSEC as "Buy", CRAI as "Buy". Consensus price targets imply 39.4% upside for CRAI (target: $194) vs 9.8% for HCSG (target: $25). For income investors, SGBX offers the higher dividend yield at 100.00% vs VSEC's 0.20%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $24.50 | $235.67 | $194.00 |
| # AnalystsCovering analysts | — | — | 15 | 11 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +100.0% | — | +0.2% | +1.5% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 20 | 0 | 9 |
| Dividend / ShareAnnual DPS | — | $13.85 | — | $0.39 | $2.06 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% | 0.0% | +5.2% |
VSEC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). DLHC leads in 1 (Valuation Metrics). 3 tied.
DLHC vs SGBX vs HCSG vs VSEC vs CRAI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DLHC or SGBX or HCSG or VSEC or CRAI a better buy right now?
For growth investors, CRA International, Inc.
(CRAI) is the stronger pick with 9. 3% revenue growth year-over-year, versus -69. 9% for Safe & Green Holdings Corp. (SGBX). CRA International, Inc. (CRAI) offers the better valuation at 17. 1x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate VSE Corporation (VSEC) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DLHC or SGBX or HCSG or VSEC or CRAI?
On trailing P/E, CRA International, Inc.
(CRAI) is the cheapest at 17. 1x versus VSE Corporation at 79. 1x. On forward P/E, CRA International, Inc. is actually cheaper at 16. 9x.
03Which is the better long-term investment — DLHC or SGBX or HCSG or VSEC or CRAI?
Over the past 5 years, VSE Corporation (VSEC) delivered a total return of +358.
5%, compared to -100. 0% for Safe & Green Holdings Corp. (SGBX). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus SGBX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DLHC or SGBX or HCSG or VSEC or CRAI?
By beta (market sensitivity over 5 years), Safe & Green Holdings Corp.
(SGBX) is the lower-risk stock at 0. 45β versus VSE Corporation's 1. 93β — meaning VSEC is approximately 334% more volatile than SGBX relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 128% for DLH Holdings Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — DLHC or SGBX or HCSG or VSEC or CRAI?
By revenue growth (latest reported year), CRA International, Inc.
(CRAI) is pulling ahead at 9. 3% versus -69. 9% for Safe & Green Holdings Corp. (SGBX). On earnings-per-share growth, the picture is similar: Safe & Green Holdings Corp. grew EPS 69. 1% year-over-year, compared to -81. 5% for DLH Holdings Corp.. Over a 3-year CAGR, VSEC leads at 18. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DLHC or SGBX or HCSG or VSEC or CRAI?
CRA International, Inc.
(CRAI) is the more profitable company, earning 7. 3% net margin versus -341. 2% for Safe & Green Holdings Corp. — meaning it keeps 7. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VSEC leads at 11. 2% versus -195. 0% for SGBX. At the gross margin level — before operating expenses — CRAI leads at 29. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DLHC or SGBX or HCSG or VSEC or CRAI more undervalued right now?
On forward earnings alone, CRA International, Inc.
(CRAI) trades at 16. 9x forward P/E versus 47. 9x for VSE Corporation — 31. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRAI: 39. 4% to $194. 00.
08Which pays a better dividend — DLHC or SGBX or HCSG or VSEC or CRAI?
In this comparison, SGBX (100.
0% yield), CRAI (1. 5% yield), VSEC (0. 2% yield) pay a dividend. DLHC, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is DLHC or SGBX or HCSG or VSEC or CRAI better for a retirement portfolio?
For long-horizon retirement investors, CRA International, Inc.
(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 5% yield, +550. 5% 10Y return). VSE Corporation (VSEC) carries a higher beta of 1. 93 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRAI: +550. 5%, VSEC: +517. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DLHC and SGBX and HCSG and VSEC and CRAI?
These companies operate in different sectors (DLHC (Unknown) and SGBX (Industrials) and HCSG (Healthcare) and VSEC (Industrials) and CRAI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DLHC is a small-cap quality compounder stock; SGBX is a small-cap income-oriented stock; HCSG is a small-cap quality compounder stock; VSEC is a small-cap quality compounder stock; CRAI is a small-cap deep-value stock. SGBX, CRAI pay a dividend while DLHC, HCSG, VSEC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.